NUWE Stock Analysis: Buy, Sell, or Hold?
NUWE - Nuwellis, Inc. Common Stock
$3.14
-0.15 (-4.56%)
▼
5d:
-1.26%
30d:
+628.54%
90d:
+188.07%
WAIT
LOW Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When NUWE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NUWE is 33.6% above its trading range ($2.35). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NUWE is 33.6% above its trading range ($2.35). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: NUWE is currently trading at $3.14, which is considered extended relative to its 30-day fair value range of $-0.27 to $2.35.
Technical Outlook: Technically, NUWE is in a downtrend. The price is approaching resistance at $0.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: NUWE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+234.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NUWE is in a downtrend. The price is approaching resistance at $0.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: NUWE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+234.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.27 -
$2.35
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+33.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 234.3% below Wall St target ($11.00)
- WARNING: Recommendation downgraded due to 33.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$-0.27 -
$2.35
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.99
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.22
Wall Street Target
$11.00
(+234.3%)
Revenue Growth (YoY)
26.2%
Earnings Growth (YoY)
-99.2%
Profit Margin
-217.2%
Share & Embed Analysis
Last updated: July 07, 2026 3:31 PM ET
Data refreshes hourly during market hours. Next update: 4:31 PM
Data refreshes hourly during market hours. Next update: 4:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUWE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 64 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 64 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 67 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 60 HOLD |
